Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials
Crossref DOI link: https://doi.org/10.1038/sigtrans.2017.54
Published Online: 2017-10-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Wen-ying
Liu, Yang
Wang, Yao
Wang, Chun-meng
Yang, Qing-ming
Zhu, Hong-li
Han, Wei-dong
Text and Data Mining valid from 2017-10-09
Version of Record valid from 2017-10-09
Article History
First Online: 9 October 2017
Competing interests
: The authors declare no conflict of interest.